Estrogen and cholesterol are more connected than most doctors discuss. Dr. Alison DiBarto Goggin breaks down exactly what estradiol does for your cardiovascular system, why midlife women see lipid shifts that have nothing to do with diet, and what functional testing and targeted support actually look like. Covers ApoB, Lp(a), MPO, hsCRP, Lp-PLA2, insulin, homocysteine, thyroid, and the production vs. clearance framework. Practical supplementation including methylfolate, folinic acid, berberine, omega-3s, bergamot, and CoQ10. This is the conversation you didn’t get at your annual physical.
Find Dr. Alison at littleblackbagmedicine.com
Quest Labs with Discount: https://us.fullscript.com/j/alison-goggin
Fullscript Supplements: https://us.fullscript.com/plans/littleblackbagmedicine-estrogen-cholesterol
Listen Here:
Transcript:
Hey, welcome back to Functional Wellness with Dr. Alison. I’m Dr. Alison DiBarto Goggin With Little Black Bag Functional Medicine, and today we are going somewhere a lot of women tell me nobody has taken them before.
We’re talking about estrogen and cholesterol. Specifically, what estrogen is actually doing inside your cardiovascular system, why that matters so much in perimenopause and menopause, and what you can actually do about it, because your standard lipid panel is probably not telling you the full story.
If you’ve ever been told your cholesterol is a little high and gotten handed a pamphlet about eating less fat, this episode is for you. And if you’ve been watching your labs shift as your hormones shift and wondering if those things are connected, they are. A hundred percent. Let’s dig in. Today we are going to talk about the reasons we have cholesterol, what it does for the body, brain, and hormones. How estrogen impacts cholesterol production and changes and lastly what you need to know so you can take steps to support your liver, see changes in your labs, and feel your best.
Before we dive in, a quick but important note. Everything I share on this podcast is for educational purposes only. I am a chiropractor and functional medicine practitioner, and I love geeking out on this stuff, but nothing here is personalized medical advice, and it does not create a provider-patient relationship between us. If you are working through your own cardiovascular health, please do that with a clinician who knows your full picture.
Segment 1: Cholesterol Is Not the Villain
I want to start with something that I think has been genuinely misrepresented in public health messaging for decades, and that is the idea that cholesterol itself is the problem.
Cholesterol is not a toxin. Your body makes it on purpose. Every cell membrane you have depends on it. Every steroid hormone you produce, including estradiol, progesterone, testosterone, and cortisol, starts with cholesterol as the raw material. Your brain houses about a quarter of your body’s total cholesterol because it needs it for synapse formation, for myelin integrity, for neurotransmitter function.
When we deprive the body of cholesterol without understanding what it does, we are not just changing a number on a lab panel. We are potentially affecting energy production, hormone availability, cellular communication, and brain function. That is a big deal, and it is rarely part of the conversation.
So the more accurate question is not ‘how do we lower cholesterol’ but rather ‘what is happening inside the environment that cholesterol is moving through?’ Because the same lipid burden that was totally fine in your 30s can start to behave very differently in midlife. And the reason for that shift is largely hormonal.
Cholesterol is the substrate. The particles that carry it are the delivery vehicles. And the vascular environment, meaning the health of your arterial walls, the degree of inflammation, the presence or absence of oxidative stress, your insulin signaling, and yes, your hormonal status, that is what determines whether those particles stay inert or start causing problems.
Segment 2: What Estrogen Does for Your Heart
Okay. So now let’s talk about estradiol specifically, because this is where it gets really important for the women listening.
Estradiol is not just your period hormone. It is also a cardiovascular protector. And when it drops, as it does in perimenopause and menopause, your vascular environment changes in ways that have direct implications for your cholesterol.
What Estradiol Supports
Endothelial function: the inner lining of your blood vessels stays more flexible and responsive with adequate estradiol. It helps those vessels dilate when they need to and stay protected from injury.
Nitric oxide production: estradiol supports the signaling that tells your blood vessels to relax. When estradiol drops, nitric oxide production decreases. Vessels become stiffer. Blood pressure rises. This is not a coincidence.
LDL receptor activity: estradiol supports the receptors on your liver cells that pull LDL particles out of circulation. When estradiol drops, those receptors become less active, meaning particles stay in circulation longer. This is one reason LDL often rises in menopause even when diet has not changed.
Inflammatory tone: estradiol has anti-inflammatory effects at the vascular level. As it declines, that protection goes away, and the endothelium, the vessel lining, becomes more reactive.
So here is what this means practically. The standard lipid panel that looked normal at 40 can look concerning at 48 not because your diet got worse or you started making worse choices, but because the hormonal environment that was quietly protecting your cardiovascular system has shifted. And if your doctor is only looking at total cholesterol and LDL without understanding that context, they are missing a huge part of the picture.
This is also why the folate conversation matters so much in midlife women. As estrogen declines, your vascular system loses a buffer. Homocysteine can creep up. Endothelial function decreases. This is when having the right forms of B vitamins, specifically methylfolate and folinic acid rather than synthetic folic acid, makes a real difference. Folinic acid is required for proper nitric oxide function. When that pathway is supported, vessels stay more responsive. When it’s not, you can end up with increased oxidative stress at the vessel wall. Methylfolate supports homocysteine clearance through the methylation cycle. Elevated homocysteine actively damages the endothelium. In midlife, where the vascular system is already more vulnerable, this compounds the problem significantly.
Synthetic folic acid, which is what’s in most supplements and fortified foods, does not reliably convert to the active forms in many women. It can actually compete at receptor sites without delivering benefit. This is one of those nuances that matters more in midlife than it did before.
Segment 3: Advanced Labs – Reading the Full Picture
Let’s talk about labs. Because I want you to be empowered to have a different conversation with your doctor, or to know what to ask for if your standard panel keeps coming back ‘normal’ or just hearing criticism about your cholesterol levels and food choices, while you feel like something is off but nothing has changed in your life other than hormones.
The standard lipid panel gives you total cholesterol, LDL, HDL, and triglycerides. That is the starting point, not the finish line.
On the cholesterol number itself: the American Heart Association sets the national reference range at 120 to 200, with anything over 200 flagged as a concern. But in practice, most midlife women are going to run over 200 simply because of hormonal biology. That number alone, without context, is not a diagnosis. Triglycerides are a related piece of this picture. A useful clinical rule of thumb is that triglycerides should run at roughly half the total cholesterol value. When they are higher than that, it is usually a signal that blood sugar regulation is off. Reactive hypoglycemia, where blood glucose rises and falls throughout the day rather than staying stable, drives triglyceride elevation and creates an inflammatory pattern that compounds cardiovascular risk. This is one of the reasons metabolic assessment is inseparable from lipid evaluation.
Here is what else I want to see when I am evaluating cardiovascular risk in a midlife woman.
Lab / Marker
Why It Matters
Functional Target
ApoB
Counts the actual number of atherogenic particles, not just the cholesterol inside them. Two people can have the same LDL-C with very different ApoB. The particles are what interact with the vessel wall.
Under 80 mg/dL is ideal in higher-risk women
Lp(a)
Largely genetic. An LDL-like particle that also interferes with clot breakdown. Independently associated with premature heart disease. Statins do not lower it and may worsen it.
Under 30 mg/dL; under 50 nmol/L on molar scale
MPO (Myeloperoxidase)
Reflects early vascular oxidative stress. Released by immune cells, it directly injures the endothelium and depletes nitric oxide. Can be elevated before plaque is detectable.
Under 420 pmol/L
Lp-PLA2
Carried on ApoB particles. Expressed by macrophages inside plaque. Reflects active inflammatory participation in established lesions.
Under 200 ng/mL
hsCRP
System-wide inflammatory marker. Tracks with cardiovascular events because inflammation drives plaque instability. Does not tell you where inflammation lives, but confirms it is present.
Under 1.0 mg/L optimal; under 2.0 mg/L acceptable
Fasting Insulin + C-Peptide
Insulin resistance drives particle overproduction in the liver. High insulin also increases PCSK9, which degrades the receptors that clear LDL from circulation.
Fasting insulin under 5 uIU/mL; HOMA-IR under 1.5
Homocysteine
Elevations damage the endothelium directly. Driven by poor methylation, low B vitamins, MTHFR variants. Important in midlife as estrogen-supported methylation declines.
Under 8 umol/L optimal
Thyroid Panel (TSH, Free T3, Free T4)
Thyroid hormone supports LDL receptor expression and hepatic clearance. Subclinical hypothyroidism is a common and overlooked driver of high LDL and ApoB.
TSH 1-2 uIU/mL; Free T3 upper third of range
Estradiol
Directly informs the vascular environment. Not just a sex hormone. When low, everything else becomes more consequential.
Context-dependent; pattern over single value
When you bring these markers together, you move from a static number to a dynamic picture. You can see whether particles are elevated because the liver is overproducing them, because clearance is inefficient, or because the environment they’re moving through has become more reactive. Those are three different clinical situations that call for three different strategies.
Pause (not menopause) Moment
I want to pause for a second.
If you are listening to this and feeling overwhelmed, if your inner voice is saying ‘why didn’t anyone tell me this’ or ‘what does this mean for me,’ I just want to say: that reaction makes complete sense. This is a lot. And the fact that you are here, that you are asking these questions, that you are trying to understand your body rather than just manage symptoms, that is not small. That is the whole thing.
Your body is not failing you. It is communicating. The shifts that happen in perimenopause and menopause are not betrayals. They are transitions. And they are transitions that come with real physiological changes that deserve real clinical attention, not a pat on the head and a ‘this is just normal aging.’
Take a breath. You are not behind. You are just now getting the information you were always supposed to have.
Segment 4: ApoB, Lp(a), and the Production vs. Clearance Framework
Okay. Let’s go a layer deeper on ApoB because I think this framework is genuinely useful and not enough people know about it.
When ApoB is elevated, there are really only two root causes. Either the liver is making too many particles, or the body is not clearing them efficiently enough. And this distinction matters enormously because those are different clinical problems.
Overproduction Pattern
If the liver is overproducing particles, you tend to see elevated triglycerides, high fasting insulin, elevated c-peptide, and insulin score abnormalities. The liver is being fed too much substrate, glucose and fructose primarily, and it is packaging the excess as lipoproteins and exporting it. In this case, the strategy is reducing production: addressing insulin signaling, reducing refined carbohydrate and fructose load, improving hepatic metabolic function. This is where berberine, omega-3 fatty acids, and sometimes GLP-1 support can be useful. It is also where medications may make the most mechanistic sense.
Clearance Pattern
If the liver is not overproducing but particles are staying in circulation too long, you often see a disproportion between ApoB and LDL-C. Lots of particles, but relatively little cholesterol in each one. Triglycerides may be normal or low. Insulin looks fine. The problem is not the input but the output. Clearance involves receptor expression and recycling, hepatic uptake, how well bile is carrying cholesterol out of the body, and thyroid function, which directly affects how many LDL receptors are expressed.
Estradiol fits directly into this clearance picture. It supports receptor activity. When it declines, clearance efficiency drops, and particles stay in circulation longer. This is a key reason why addressing hormonal status is a legitimate cardiovascular intervention, not just a quality of life consideration.
Lp(a) is in a separate category entirely. It is largely genetic. Diet, exercise, and statins do not reliably lower it. PCSK9 inhibitors do reduce it somewhat, typically 20 to 30 percent, but whether that translates directly to mortality benefit is still being studied. For now, management means aggressively addressing everything around it: inflammation, endothelial function, glycemic stability, thrombotic risk.
Segment 5: Nutritional and Supplement Support
So what can you actually do? Let’s talk about the levers available to you, beyond pharmaceuticals and really in support of the whole system.
Nutritional Foundations
Reduce added sugar and refined fructose. The JAMA Internal Medicine data from 2014 showed that getting 25 percent or more of calories from added sugar more than doubled cardiovascular mortality risk, independent of weight, physical activity, and cholesterol levels. This is not about fat. It is about sugar-driven metabolic dysfunction.
Prioritize fiber. Soluble fiber binds bile acids and increases their excretion, which forces the liver to use cholesterol to replace them and drives LDL receptor activity. This is a clearance strategy that also supports the microbiome.
Omega-3 fatty acids. Support triglyceride reduction, reduce inflammatory signaling, improve particle quality. EPA and DHA in therapeutic doses, typically 2 to 4 grams per day, are worth the investment.
Support methylation through food. Leafy greens, legumes, and eggs are high in natural folate and choline. These support the methylation pathways that keep homocysteine in check.
Targeted Supplementation
Methylfolate and folinic acid (not folic acid). As discussed, these support nitric oxide signaling through BH4 and homocysteine clearance through methylation. Critical distinction in midlife women.
Berberine. A natural AMPK activator that improves insulin signaling, reduces hepatic triglyceride production, and supports LDL receptor activity. Also modulates PCSK9. Works on the clearance side and the production side.
Bergamot. Citrus polyphenols that work similarly to berberine. Supports cholesterol synthesis regulation and particle quality.
Green tea may help if you have no autoimmunity. Supports energy sensing and hepatic lipid handling. Reduces inflammatory tone.
Quercetin and curcumin. Support the intracellular signaling environment that affects how the liver produces and clears lipoproteins.
Pantethine (active B5). Improves hepatic fatty acid oxidation, which reduces triglyceride buildup and the downstream need to export fat as VLDL. Lowers ApoB indirectly when triglycerides are the driver.
Magnesium. Supports insulin sensitivity, blood pressure regulation, vascular tone, and methylation. Chronically under-consumed in the Western diet.
CoQ10. Especially if statins are already in the picture. Statins suppress the same pathway that produces CoQ10, and CoQ10 is essential for mitochondrial energy production and cellular repair.
Nitric Oxide support: Contains a proprietary blend of ingredients such as ATP, xanthinol nicotinate, N-acetyl L-carnitine, alpha-GPC, vinpocetine, and huperzine A, which work synergistically to support cellular energy and neurovascular health.
Hormone Optimization
This deserves its own episode, but in brief: estradiol replacement, when appropriate and with proper evaluation, is not just a menopause symptom treatment. It is a cardiovascular intervention. It supports LDL receptor activity, endothelial function, nitric oxide signaling, and inflammatory tone. The timing and delivery method matter. Transdermal estradiol appears to carry fewer clotting risks than oral forms. This is a conversation worth having with a clinician who understands functional and integrative medicine, not just symptom management.
Closing
Okay. Let me land this information for you, and if you find it overwhelming or you want to dive deeper, click the link to my blog where I have the transcript saved for you as well as the charts, labs, and links.
Cardiovascular disease is not a cholesterol problem. It is a systems problem. It involves particles, yes, but also the environment those particles are moving through, the metabolic state of the body producing and clearing them, the inflammatory and oxidative tone of the vessels, and, critically for midlife women, the hormonal biology that was quietly protecting all of it.
The standard lipid panel is a starting point. Advanced markers like ApoB, Lp(a), MPO, Lp-PLA2, and hsCRP give you a much more complete picture. And when you layer in estradiol, thyroid, insulin, and homocysteine, you stop looking at a number and start reading the whole system.
You do not have to accept ‘your labs are fine’ when something feels off. You do not have to accept ‘this is just part of aging’ when your body is clearly trying to tell you something. You get to ask for more. You get to want more. And the information exists to actually give it to you.
If you want to dig deeper into any of this, reach out. You can find me at littleblackbagmedicine.com. I work with women in functional medicine consultation and through ongoing care, and I love this exact kind of clinical detective work.